REX American Resources Corporation (REX)
NYSE: REX · Real-Time Price · USD
0.00
+0.4800 (1.10%)
Apr 21, 2026, 9:45 AM EDT - Market open
Company Description
REX American Resources Corporation, together with its subsidiaries, produces and sells ethanol in the United States.
The company provides corn, distillers grains, ethanol, distillers corn oil, gasoline, and natural gas.
It also offers dry distillers grains with soluble, which is used as a protein in animal feed. REX American Resources Corporation was formerly known as REX Stores Corporation and changed its name to REX American Resources Corporation in June 2010.
The company was founded in 1980 and is headquartered in Dayton, Ohio.
REX American Resources Corporation
| Country | United States |
| Founded | 1980 |
| Industry | Chemicals |
| Sector | Materials |
| Employees | 132 |
| CEO | Zafar Rizvi |
Contact Details
Address: 7720 Paragon Road Dayton, Ohio 45459 United States | |
| Phone | 937 276 3931 |
| Website | rexamerican.com |
Stock Details
| Ticker Symbol | REX |
| Exchange | NYSE |
| Fiscal Year | February - January |
| Reporting Currency | USD |
| CIK Code | 0000744187 |
| CUSIP Number | 761624105 |
| ISIN Number | US7616241052 |
| Employer ID | 31-1095548 |
| SIC Code | 2860 |
Key Executives
| Name | Position |
|---|---|
| Zafar A. Rizvi | Chief Executive Officer, President and Director |
| Stuart A. Rose | Executive Chairman and Head of Corporate Development |
| Douglas L. Bruggeman | Vice President of Finance, Chief Financial Officer and Treasurer |
| Edward M. Kress | Secretary and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 15, 2026 | ARS | Filing |
| Apr 15, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 15, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 31, 2026 | 144 | Filing |
| Mar 30, 2026 | 10-K | Annual Report |
| Mar 27, 2026 | SCHEDULE 13G/A | Filing |
| Mar 27, 2026 | PRE 14A | Other preliminary proxy statements |
| Mar 26, 2026 | 8-K | Current Report |
| Feb 12, 2026 | SCHEDULE 13G/A | Filing |
| Dec 4, 2025 | 10-Q | Quarterly Report |